Our investment portfolio demonstrates a focus on large unmet or underserved market opportunities with a view toward value creation through the development of novel technologies with clear points of differentiation versus existing standards of care. The breadth of our focus in each sector is illustrated by the range of therapeutic focus and diversity of technologies within our portfolio companies. Our professionals are focused on opportunities in biopharmaceuticals, information convergence, medical devices and biological research tools and infrastructure technology. A selected list of our current and exited portfolio company investments is presented via the following categories:

The companies listed do not represent a complete list of all of our team’s current and historical portfolio company investments.